The University of Southern Mississippi

The Aquila Digital Community
Honors Theses

Honors College

Spring 5-2019

When Saliva Is a Crime: Reforming Mississippi’s HIV
Criminalization Law Utilizing the Center for Disease Control and
Prevention’s Policy Analytical Framework
Anastasia Walrod
University of Southern Mississippi

Follow this and additional works at: https://aquila.usm.edu/honors_theses
Part of the Other Public Health Commons

Recommended Citation
Walrod, Anastasia, "When Saliva Is a Crime: Reforming Mississippi’s HIV Criminalization Law Utilizing the
Center for Disease Control and Prevention’s Policy Analytical Framework" (2019). Honors Theses. 629.
https://aquila.usm.edu/honors_theses/629

This Honors College Thesis is brought to you for free and open access by the Honors College at The Aquila Digital
Community. It has been accepted for inclusion in Honors Theses by an authorized administrator of The Aquila
Digital Community. For more information, please contact Joshua.Cromwell@usm.edu.

The University of Southern Mississippi

When Saliva Is a Crime: Reforming Mississippi’s HIV Criminalization Law Utilizing the Center
for Disease Control and Prevention’s Policy Analytical Framework

by

Anastasia Walrod

A Thesis
Submitted to the Honors College of
The University of Southern Mississippi
in Partial Fulfillment
of Honors Requirements

May 2019

ii

Abstract
Mississippi is currently experiencing an HIV/AIDS crisis. The state is ranked in the top
10 for diagnoses of HIV infection, with Jackson, Mississippi ranked sixth in the nation for HIV
diagnoses and fourth in the nation for AIDS diagnoses. Despite antiretroviral treatment allowing
for persons with HIV to lead healthy lives, Mississippians continue to die from AIDS in large
part because of stigma, misinformation, and lack of resources. This is furthered by Mississippi’s
HIV criminalization law. HIV criminalization laws are used to penalize HIV exposure, but HIVspecific criminal laws are considered largely ineffective public health policies because these
statutes further stigmatize, do not account for lack of criminal intent, include misinformation,
and do not reduce infection rates. Mississippi Code ANN. § 97-27-14 perpetuates all of these
issues by including saliva, urine, and feces as a crime of endangerment by bodily substance, even
though these substances have very low risk of transmitting HIV. In this study, Mississippi’s
existing policy was identified using the Center for Disease Control and Prevention’s Policy
Analytical Framework, and three possible policy options were analyzed and scored based on
public health impact, feasibility, and economic and budgetary impact. Results of this analysis
strongly indicate that Mississippi Code ANN. § 97-27-14 should be amended to be scientifically
accurate and include a criminalization clause based on the National HIV/AIDS Strategy for the
United States goals and the United States Department of Justice Civil Rights Division best
practices.

Key words: HIV/AIDS, HIV-specific criminalization laws, HIV criminalization, Mississippi,
crime of endangerment by bodily substance, Mississippi Code ANN. § 97-27-14
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Chapter 1: Introduction
In the United States of America, new incidences of HIV have significantly decreased in
large part because of prevention efforts and drugs such as antiretroviral therapy, pre-exposure
prophylaxis, and post-exposure prophylaxis that greatly reduce possible transmission. Despite
tremendous progress, these trends are not seen in the Deep South where HIV rates continue to
rise. From 2006 to 2015, newly diagnosed cases of HIV in Mississippi rose by 10% (Mississippi
State Department of Health, STD/HIV Office, 2016). In Mississippi, almost 80% of diagnoses
and mortality rates are African Americans showcasing a large health disparity (Mississippi State
Department of Health, STD/HIV Office, 2016). To further this issue, Mississippi has the second
highest percentage for prisoners living with HIV (Maruschak & Bronson, 2017). Mississippi is
experiencing a HIV/AIDS crisis, and this crisis is further exacerbated by Mississippi HIV
criminalization law.
HIV-specific criminalization laws are criminal statues used to prosecute and punish those
living with HIV. These laws were created to inhibit the spread of HIV and protect others from
being exposed to HIV, yet HIV criminalization is considered ineffective public health policy.
These statues are stigmatizing, do not account for lack of criminal intent or transmission, include
misinformation, and do not reduce infection rates. Mississippi HIV criminalization law,
Mississippi Code Ann. § 97-27-14, embodies these implications as the statute includes
scientifically incorrect information, a stigmatizing discrepancy between a misdemeanor and
felony only based on knowing one’s HIV status, and is HIV-specific. The Center for Disease
Control and Prevention and the United States Department of Justice recommends that states
reform HIV-specific criminal laws by repealing the statues, but, if this is not feasible, to amend
the policies to be scientifically correct and include a criminal intent clause.
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The purpose of this study was to prioritize the most appropriate policy option to reform
Mississippi HIV criminalization law. Using Center for Disease Control and Prevention’s Policy
Analytical Framework, policy options were developed, analyzed, and prioritized based on public
health impact, feasibility, and economic and budgetary impact. Results were analyzed, and a
strategy was created to reform Mississippi HIV criminalization to be more equitable.
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Chapter 2: Literature Review
HIV/AIDS Basics
HIV stands for human immunodeficiency virus, and if the virus if left untreated leads to
AIDS, which is acquired immunodeficiency syndrome. HIV attacks the body’s immune system
by targeting CD4 T lymphocytes , commonly known as CD4 cells or T cells (HIV.gov, 2017).
CD4 T lymphocytes “help coordinate the immune response by stimulating other immune cells…
to fight off infection;” through the destruction of these white blood cells, HIV weakens the
immune system leaving the individual more susceptible to infections (AIDSinfo, n.d.). HIV is
spread from a person who has HIV through certain bodily fluids including “blood, semen (cum),
pre-seminal fluid (pre-cum), rectal fluids, vaginal fluids, and breast milk” (Center for Disease
Control and Prevention, 2018b). This transmission is done via certain behaviors with the most
common modes of transmission in the United States being unprotected sex and re-use of needles
from intravenous drugs, yet transmission can occur if the virus comes in contact with a mucous
membrane, damaged tissue, or bloodstream (Center for Disease Control and Prevention, 2018b).
There is currently no cure for HIV/AIDS, but antiretroviral treatments allow for the prevention
and management of HIV/AIDS. If left untreated, HIV progresses to three stages: the acute HIV
infection stage, the chronic HIV infection stage, and then finally AIDS (HIV.gov, 2017).
Acute HIV infection occurs 2-4 weeks after HIV infection and is the first stage of HIV.
This stage is often characterized by flu-like symptoms including headaches, rashes, and fever
(AIDSinfo, 2018). Despite this characterization, many people do not experience these symptoms
and “are often unaware that they’re infected because they may not feel sick right away or at all”
(Center for Disease Control and Prevention, 2019a). During the acute HIV infection stage, the
virus is extensively produced causing CD4 T lymphocytes counts to fall rapidly. Because of the
high levels of virus production, individuals “are at very high risk of transmitting HIV to… sexual
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or needle-sharing partners” (HIV.gov, 2017). Eventually, the immune system responds to the
HIV infection, and the “rapid replication of HIV declines and the person's viral load drops to its
set point” meaning that the HIV viral load stabilizes (AIDSinfo, 2019). Once the viral load
reaches the set point, CD4 T lymphocytes counts begin to rise, but the levels “may not return to
pre-infection levels” (HIV.gov, 2017).
The acute HIV stage eventually progresses to the chronic HIV infection stage commonly
called “clinical latency.” This second stage is characterized by individuals experiencing little or
no HIV related symptoms. The virus reproduces at extremely low levels and “cannot be detected
with standard laboratory tests” (HIV.gov, 2017). Despite the low viral load, HIV can still be
spread to others during the chronic infection stage (Center for Disease Control and Prevention,
2019a). Without any treatment, this stage can last approximately 10 years and eventually
advances to AIDS (AIDSinfo, 2018).
AIDS is the final stage of HIV infection. This is the most severe stage of HIV and is
characterized by opportunistic infections, very low numbers of CD4 T lymphocytes, and
common symptoms including: “chills, fever, sweats, swollen lymph glands, weakness, and
weight loss” (Center for Disease Control and Prevention, 2019a). For diagnosis, one is
considered to have progressed to AIDS if CD4 T lymphocytes fall below 200 cells per cubic
millimeter of blood or if the individual develops an opportunistic illness (AIDSinfo, 2018).
Concerning cell counts, a normal number of CD4 T lymphocytes ranges from 500 to 1,500
meaning that persons living with AIDS have less than 50% to less than 10% of the normal cell
count (U.S. Department of Veterans Affairs, 2018). Concerning opportunistic infections, these
are infections that take advantage of a weakened immune system and include diseases such as
cryptococcal meningitis, toxoplasmosis, esophageal candidiasis, and other infections (Avert,
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2018). Without treatment, those with AIDS live for approximately 3 years, but this is often
shortened if exposed to an opportunistic illness (AIDSinfo, 2018).
If an individual contracts HIV, the virus can be managed through antiretroviral therapy,
commonly known as ART. ART consist of various medications that treat HIV by preventing the
growth of the virus. Antiretroviral drugs, commonly referred to as ARV, are not cures for
HIV/AIDS, but when used in combination (combination therapy) allow for reduced viral load
(The AIDS InfoNet, 2014). When using ART, the person living with HIV’s viral load can be
undetectable meaning that if they were to test for HIV, they would test negative and would not
be able to transmit the virus. These drugs should begin to be taken once tested positive for HIV
and allows for persons living with HIV/AIDS to live long, healthy lives.
HIV/AIDS can be prevented through certain behaviors and drugs. The only methods that
absolutely prevent the spread of HIV/AIDS are abstinence and not sharing needles from
intravenous drugs, but there are numerous other very effective methods. Other prevention
methods include limiting number of sexual partners, using condoms correctly every time the
individual has sex, and taking “advantage of newer HIV prevention medicines such as preexposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP)” (Center for Disease Control
and Prevention, 2019c)
PrEP and PEP are antiretroviral drugs used to reduce one’s susceptibility of contracting
HIV. PEP is a HIV prevention drug used in emergency situations where the individual could
have been potentially exposed to HIV (Center for Disease Control and Prevention, 2018d). PEP
is a pill taken “once or twice daily for 28 days” and must be administered within 72 hours after
being possibly exposed (HIV.gov, 2018). PrEP is “a new HIV prevention approach where HIVnegative individuals use anti-HIV medications to reduce their risk of becoming infected if they
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are exposed to the virus” (San Francisco AIDS Foundation, 2018). Essentially, this is a pill taken
by those who do not have HIV and it greatly reduces chances of contracting HIV by blocking the
virus from reproducing. Studies have shown that when taken daily, “PrEP reduces the risk of
getting HIV from sex by more than 90%” and “reduces the risk of getting HIV by more than
70%” (Center for Disease Control and Prevention, 2019b). These drugs greatly reduce one’s risk
of contracting HIV if properly taken.
HIV/AIDS in the United States
Currently, there are approximately 1.1 million people living in the United States with
HIV and half of these people are virally suppressed (HIV.gov, 2019). Nationally, annual rates of
HIV infections and diagnoses are declining, which is attributed to HIV prevention initiatives
such as education, resources, and drugs (Center for Disease Control and Prevention, 2018a).
Despite the nationally decreasing trend, the Deep South region of the United States
consisting of Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina,
and Texas “has been disproportionately affected by HIV, as this region has consistently
experienced the highest HIV diagnosis rates and death rates of any US region” (Reif et al.,
2017). This alarming HIV/AIDS trend in the Deep South continues as almost 50% of those living
with HIV/AIDS are in the Southern United States despite this area making up less than 40% of
the nation’s population (McAllaster, 2014). Minority populations are especially impacted by
HIV/AIDS diagnoses and deaths as African Americans represent the majority of new incidences
and prevalence of HIV/AIDS in the Deep South. This is especially prevalent in “new diagnoses
among African American men who have sex with men” (Reif et al., 2017).
Another important population that is disproportionately impacted by HIV/AIDS in the
United States are those incarcerated. According to the Bureau of Justice Statistics, there are
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approximately 2,162, 400 incarcerated people in the United States (Kaeble & Cowhig, 2018).
This mass incarceration in the United States has a “high concentration of HIV infection within
correctional facilities;” this in part of because of imprisonment of those for “illicit drug use” and
drug laws leading “to substantial increase in incarceration rates for African American men,”
which are both populations that have higher rates of HIV (Whol, 2016). In 2015, there were
approximately 17,000 prisoners with HIV (Maruschak & Bronson, 2017). This translates to
approximately 1.3% of “prisoners who had HIV as a percent of custody population” (Maruschak
& Bronson, 2017). To further elaborate, “an estimated 14% of all persons living with HIV
infection in the United States, and 20% of African American HIV-Infected individuals, pass
through a jail or prison each year” further showing the HIV prevalence in prisons (Wohl, 2016).
HIV disproportionately impacts African American males in the prison system even with the fact
that national HIV trends in the incarcerated are falling (Maruschak & Bronson, 2017).
HIV/AIDS in Mississippi
Mississippi follows trends seen in the Deep South. From 2006 to 2015, “there was a 10%
increase in the number of newly reported HIV diagnoses in the state of Mississippi” juxtaposing
national decreases (Mississippi State Department of Health, STD/HIV Office, 2016). In 2015,
there were approximately 10,000 people living with HIV/AIDS, and of this population, almost
80% were African American; this translates to “the rate of Black males living with an HIV
diagnosis is 5.4 times that of White males” and “the rate of Black females living with an HIV
diagnosis is 9.6 times that of White females” (AIDSVu, 2018). This health disparity that African
Americans make up approximately 40% of Mississippi’s population yet make up 80% of
incidences, prevalence, and deaths among those living with HIV (Mississippi State Department
of Health, STD/HIV Office, 2016). Mississippi also followed regional trends in that the primary
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transmission rate of HIV was through men having sex with men (AIDSVu, 2018). In relation to
other states in the nation, Mississippi is the ninth in the nation for new diagnoses of HIV rate and
sixth in the nation for the rate of AIDS diagnoses; Jackson, Mississippi ranked sixth highest for
diagnoses of HIV and fourth highest for AIDS diagnoses (Center for Disease Control and
Prevention, 2018a). These numbers showcase that despite effective treatment, HIV transmission
and death by AIDS continue to remain prevalent in Mississippi.
HIV/AIDS in Mississippi’s prison population also show alarming trends. There are
approximately 29,000 people incarcerated in Mississippi; Hispanics make up the majority of the
population followed by African Americans, Native Americans, and lastly Caucasians (Prison
Policy Initiative, n.d.). There are approximately 2.1% of “prisoners who had HIV as a percent of
custody population,” which is the second highest percentage in the nation (Maruschak &
Bronson, 2017). Mississippi’s alarming rates of HIV/AIDS are also prevalent in the prison
system.
HIV Criminalization Nationally
HIV criminalization is defined as “use of criminal law to penalize alleged, perceived, or
potential HIV exposure; alleged nondisclosure of a known HIV-positive status prior to sexual
contact (including acts that do not risk HIV transmission); or non-intentional HIV transmission”
(The Elizabeth Taylor AIDS Foundation, 2018). This is the “application of criminal law to
people living with HIV based solely on their HIV status,” and many of these statutes “allow
prosecution for acts that constitute no or very little risk by failing to recognize condom use or
low viral load or by criminalizing spitting, biting, scratching or oral sex” (Bernard & Cameron,
2016). HIV criminalization laws were first enacted in 1986 (Lehman et al., 2014). Prosecution of
these laws first emerged in the United States in 1987, five years after the United States
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recognized AIDS as a medical disorder and one year after the virus became known as HIV; this
was a time of widespread panic exacerbated by “inaccurate and contradictory public health
statements and media reports regarding transmission of the agent” (Bernard, 2010). Justifications
of these laws are public health measures “to inhibit the spread of HIV” and “protect persons from
exposure to infection with HIV” (Cameron, 2009).
From a 2014 review cosponsored by the Centers for Disease Control and Prevention and
the U.S. Department of Justice, in the United States there are currently “33 states that have one
or more HIV-specific criminal laws” making up 67 laws (Lehman et al., 2014). Of these states,
“24 require persons who are aware that they have HIV to disclose their status to sexual partners,”
14 states “require disclosure to needle-sharing partners,” 13 states “criminalize
prostitution/solicitation,” 11 states “criminalize behaviors such as biting, spitting, and throwing
bodily fluids, most often in the context of prisons and correctional facilities,” 19 states
“criminalize donating blood,” and “HIV-specific criminal laws are classified as felonies in 28
states” (Lehman et al., 2014). Most of these laws “were passed before studies showed that
antiretroviral therapy (ART) reduces HIV transmission risk and most laws do not account for
HIV prevention measures that reduce transmission risk, such as condom use, ART, or preexposure prophylaxis” (Lehman et al., 2014).
Using HIV criminalization law, there have been at least 104 convictions and/or
prosecutions between 2013 and 2015 (Bernard & Cameron, 2016). Since being enacted in 1987,
“a reported national total of at least 350 prosecutions” have occurred (UNAIDS, 2012). This data
is difficult to assess on a national level “because state-level prosecution and arrest data are not
readily available in any national legal database,” so “the number of prosecutions, arrests, and
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instances where HIV-specific criminal laws are used to induce plea agreements is unknown”
(Lehman et al., 2014).
HIV Criminalization in Mississippi
Mississippi Code also reflects HIV criminalization. Mississippi Code ANN. § 97-27-14
criminalizes “causing exposure to human immunodeficiency virus (HIV)” and the “crime of
endangerment by bodily substance.” Mississippi Code ANN. § 97-27-14 states:
“(1) It shall be unlawful for any person to knowingly expose another person to human
immunodeficiency virus (HIV), hepatitis B or hepatitis C. Prior knowledge and willing
consent to the exposure is a defense to a charge brought under this paragraph. A violation
of this subsection shall be a felony.
(2)
(a) A person commits the crime of endangerment by bodily substance if the person
attempts to cause or knowingly causes a corrections employee, a visitor to a correctional
facility or another prisoner or offender to come into contact with blood, seminal fluid,
urine, feces or saliva.
(b) As used in this subsection, the following definitions shall apply unless the context
clearly requires otherwise:
(i) “Corrections employee” means a person who is an employee or contracted employee
of a subcontractor of a department or agency responsible for operating a jail, prison,
correctional facility or a person who is assigned to work in a jail, prison or correctional
facility.
(ii) “Offender” means a person who is in the custody of the Department of Corrections.
(iii) “Prisoner” means a person confined in a county or city jail.
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(c) A violation of this subsection is a misdemeanor unless the person violating this
section knows that he is infected with human immunodeficiency virus (HIV), hepatitis B
or hepatitis C, in which case it is a felony.
(3) Any person convicted of a felony violation of this section shall be imprisoned for not
less than three (3) years nor more than ten (10) years and a fine of not more than Ten
Thousand Dollars ($10,000.00), or both.
(4) Any person guilty of a misdemeanor violation of this section shall be punished by
imprisonment in the county jail for up to one (1) year and may be fined One Thousand
Dollars ($1,000.00), or both.
(5) The provisions of this section shall be in addition to any other provisions of law for
which the actions described in this section may be prosecuted.”
This law was enacted in 2004, almost 20 years after first HIV laws emerged. Only three
states have enacted HIV criminalization laws after Mississippi (Lehman et al., 2014). Since
2004, there have been two prosecutions and two convictions under this code (Sero, n.d.).
Implications of HIV Criminalization
HIV criminalization is considered ineffective public health public health policy as
advocated by countless HIV/AIDS organizations and research. The four primary arguments
against HIV criminalization are that these statues further stigma, unnecessarily criminalize those
who do not have criminal intent, do not reflect current scientific information, and are ineffective
at reducing prevalence.
Stigma plays a central role in HIV criminalization. “Overall, two-thirds (22 of 33) of
states enacted their first [HIV criminalization] law” before 1990 meaning that most states that
have HIV criminalization statutes passed in the midst of the AIDS epidemic, a time in American
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history filled with fear, confusion, and misinformation surrounding the disease (Lehman et al.,
2014). HIV/AIDS has been stigmatized for two primary reasons: “the fact that HIV is sexually
transmitted and the fact that it is predominantly found in groups that are already socially
disfavored or marginalized: gay men, the poor, black Africans, women, those who use drugs, sex
workers;” the stigma often contributed to the enactment of these laws (Cameron, 2009). In the
publication by the HIV Justice Network and the Global Network of People Living with HIV
(GNP+) entitled Advancing HIV Justice 2, Edwin Cameron, Constitutional Court of South Africa
and HIV activist, states:
“The enactment and enforcement of HIV-specific criminal laws – or even the threat of
their enforcement – fuels the fires of stigma. It reinforces the idea that HIV is shameful,
that it is a disgraceful contamination. And by reinforcing stigma, HIV criminalization
makes it more difficult for those at risk of HIV to access testing and prevention. It also
makes it more difficult for those living with the virus to talk openly about it, and to be
tested, treated and supported” (Bernard & Cameron, 2016).
In the criminalization of HIV/AIDS, shame and fear are reinforced, which can discourage
individuals from accessing needed testing and resources. Ultimately, these laws are enacted
because of stigma associated with HIV/AIDS, and these laws further foster stigma associated
with HIV/AIDS.
Another reason that HIV criminalization is considered poor public health methodology is
that these laws punish those without criminal intent. HIV-specific criminal law “fails to uphold
the legal and judicial fairness (including key criminal law principles of legality, foreseeability,
intent, causality, proportionality, and proof)” (Bernard & Cameron, 2016). HIV criminality
allows for prosecution of those who did not transmit the disease and had no criminal intent.
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Edwin Cameron states “defendants have been punished less for what they did than for the virus
they carried” meaning that the crime is more associated with HIV than the specified act
(Cameron, 2009).
HIV-specific criminalization laws are also ineffective because the statues often do not
reflect current scientific information. These policies are filled with “persistent misinformation
about routes of HIV transmission,” which showcase that the policies are based on ignorance
and/or stigma (Kelly, 2012). Saliva, urine, feces, and biting are commonly included in HIVspecific criminalization laws, yet these bodily fluids and actions pose negligible risk for viral
transmission. Scientifically incorrect information misleads individuals in how HIV is transmitted
and criminalizes those living with HIV for exposing others to HIV even though their actions and
bodily fluids cannot transmit HIV. Ultimately. HIV-specific criminalization laws that include
incorrect scientific information spread misinformation encouraging stigma and criminalize those
living with HIV for no harm committed.
Despite being enacted to inhibit the spread of HIV and protect others from getting HIV,
HIV-specific criminalization laws do not work. There is a “general lack of evidence that HIVspecific criminal laws have reduced transmission” (Lehman et.al., 2014). Numerous studies have
shown limited impact of HIV-specific criminal laws on reducing HIV rates, even though the
primary reason these laws exist are to reduce transmission rates.
Ultimately, HIV-specific criminal laws undermine HIV prevention, treatment, and care
efforts. Studies have exhibited that “there is no good public health reason to treat sexual behavior
involving HIV exposure as a crime, and… it is very difficult or impossible to do so fairly”
(Burris, Beletsky, Burleson, Case, and Lazzarini, 2007). These laws are HIV-specific meaning
that “the laws only apply to people who know their status” causing the statues to have the
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potential to be “powerful disincentives for voluntary testing” (Burris et. al., 2007). These HIVspecific statues further stigma while singling out those living with HIV, which can discourage
testing, further transmission of the virus by those who do not test, and discourage those living
with HIV to access needed resources. HIV-specific criminal statues hinder prevention, treatment,
and care efforts, whose efforts significantly reduce the spread of HIV and decrease the chances
of HIV progressing to AIDS.
Best Practices
In a study published by both the Center for Disease Control and Prevention and the
United States Department of Justice, HIV-specific criminal state laws were analyzed to conclude
that states should “assess the laws’ alignment with current evidence regarding transmission risk,
and consider whether the laws are the best vehicle to achieve their intended purposes” (Lehman
et.al., 2014). This suggestion was furthered by the United States Department of Justice Civil
Rights Division’s publication entitled Best Practices Guide to Reform HIV-Specific Criminal
Laws to Align with Scientifically-Supported Factors (2014). The publication states:
“Generally, the best practice would be for states to reform these laws to eliminate HIVspecific criminal penalties except in two distinct circumstances. First, states may wish to
retain criminal liability when a person who knows he/she is HIV positive commits a
(non-HIV specific) sex crime where there is a risk of transmission (e.g., rape or other
sexual assault). The second circumstance is where the individual knows he/she is HIV
positive and the evidence clearly demonstrates that individual’s intent was to transmit the
virus and that the behavior engaged in had a significant risk of transmission, whether or
not transmission actually occurred.” (U.S. Department of Justice Civil Right Division,
2014).
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These findings are further validated by the National HIV/AIDS Strategy for the United
States: Updated to 2020. This strategy includes the United States Department of Justice Civil
Rights Division best practices to reform HIV-specific criminal laws in their list of achievements
and include in their recommended actions for state governments to ensure their “criminal laws
reflect current scientific information regarding HIV transmission and prevention” and that “antistigma civil rights messages” are in Federal documents (The White House Washington, 2015).

These studies and governmental publications show that the ideal public health solution
for HIV-specific criminal laws is to repeal these statues to alleviate stigma related to these
policies. If repeal is not possible, then these statutes should be reexamined and amended to be
scientifically accurate, include a clause for criminal intent, and reduce stigma.
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Chapter 3: Statement of Problem
Amidst national decreasing trends, Mississippi’s HIV/AIDS prevalence continues to
increase. This predominantly impacts African American men who make up 74% of persons
living with HIV and 68% of death by AIDS. Despite the availability of antiretroviral drugs that
allow for people living with HIV to lead healthy lives, Mississippians are still dying of AIDS at
alarming rates. These trends are also seen in the Mississippi prison system as Mississippi is the
fourth highest in the nation for prisoners who had HIV as percent of custody population. These
issues are further complicated by Mississippi’s HIV-specific criminal law, Mississippi Code
Ann. § 97-27-14. The statute relates to the crime of endangerment by bodily substance as applied
to the prison population and includes urine, feces, and saliva, which are scientifically incorrect
modes of HIV transmission. Based on national publications including the National HIV/AIDS
Strategy for the United States: Updated to 2020 and the U.S. Department of Justice Civil Rights’
Best Practices Guide to reform HIV-Specific Criminal Laws to Align with ScientificallySupported Factors, HIV-specific criminal laws should be reformed to reflect accurate scientific
information and to prevent further stigma to persons living with HIV. Despite all these factors,
the Mississippi State Department of Health’s 2017-2021 Integrated HIV Prevention and Care
Plan explicitly states that HIV-related criminal laws in Mississippi exist, but “before HIV
decriminalization can happen, capacity building and awareness raising first occur and will be the
focus of our efforts for the first year of this plan” and does not give a 5 year plan to holistically
address HIV criminalization laws nor mention any plan related to the high prevalence of
prisoners with HIV. Criminal laws serve as written guide for morality and justice. In having
public health criminal statues based on unscientific and unrecommended information,
Mississippi Code Ann. § 97-27-14 further perpetuates a culture of stigma for HIV/AIDS
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furthering the Mississippi HIV/AIDS crisis. Mississippi Code Ann. § 97-27-14 must be
methodologically reformed to reflect national standards.
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Chapter 4: Method
I used the CDC’s Policy Analytical Framework to develop and analyze different HIVspecific policy options for Mississippi based on suggestions from the National HIV/AIDS
Strategy for the United States: Updated to 2020 and the U.S. Department of Justice Civil Rights’
Best Practices Guide to reform HIV-Specific Criminal Laws to Align with ScientificallySupported Factors. The CDC’s Policy and Analytical Framework consists of three domains:
Problem Identification, Policy Analysis, and Strategy and Policy Development.
Domain 1 is Problem Identification; this consists of “identify[ing] the problem or issue”
to have a specific issue/problem that would enable a “clear policy solution” (Centers for Disease
Control and Prevention, 2013). Problem Identification consists of “synthesiz[ing] data on the
characteristics of the problem or issue, including the burden (how many people it affects),
frequency (how often it occurs), severity (how serious the problem is), and scope (range of
outcomes it affects)” (Centers for Disease Control and Prevention, 2013). Ultimately, the issue or
problem is clearly identified.
Domain 2 is Policy Analysis. Policy Analysis consists of three main parts: “identify and
describe policy options,” “assess policy options,” and “prioritize policy options” (Centers for
Disease Control and Prevention, 2013). Identifying policy options consists of researching
possible options related to the problem or issue. This includes conducting a literature review,
looking at best practices, and performing an environmental scan to see what other
states/jurisdictions have done. Describing policy options consists of elaborating on the options
identified. This step includes answering framing questions “to describe the process and structure
as well as the questions for each of the three interrelated criteria: health impact feasibility, and
economic and budgetary impacts” (Table 1) (Centers for Disease Control and Prevention, 2013).
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Table 1: Policy Analysis: Key Questions
Framing Questions
What is the policy lever – is it legislative,
administrative, regulatory, other?
What level of government institution will
implement?
How does the policy work/operate? (e.g. is it
mandatory? Will enforcement be necessary?
How is it funded? Who is responsible for
administering the policy?)
What are the objectives of the policy?
What is the legal landscape surrounding the
policy (e.g. court rulings, constitutionality)?
What is the historical context (e.g. has the
policy been debated previously)?
What are the experiences of other
jurisdictions?
What is the value-added of the policy?
What are the expected short, intermediate,
and long-term outcomes?
What might be the unintended positive and
negative consequences of the policy?

Public Health Impact: Potential for the policy to impact risk factors, quality
of life, disparities, morbidity and mortality
How does the policy address the problem or
issue (e.g., increase access, protect from
exposure)?
What are the magnitude, reach, and
distribution of benefit and burden (including
impact on risk factor, quality of life,
morbidity and mortality?
What population(s) will benefit? How much?
When?
What population(s) will be negatively
impacted? How much? When?
Will the policy impact health
disparities/health equity? How?
Are there gaps in the data/evidence-base?

Feasibility*: Likelihood that the policy can be successfully adopted and
implemented
Political
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What are the current political forces
including political history, environment, and
debate?
Who are the stakeholders, including
supporters and opponents? What are their
interests and values?
What are the potential social, educational,
and cultural perspectives associated with the
policy option (e.g. lack of knowledge, fear of
change, force of habit)?
What are the potential impacts of the policy
on other sectors and high priority issues (e.g.
sustainability, economic impact)?
Operational
What are the resource, capacity, and
technical needs developing, enacting, and
implementing the policy?
How much time is needed for the policy to
be enacted, implemented, and enforced?
How scalable, flexible, and transferable is
the policy?
*In assessing feasibility, identifying critical barriers that will prevent the policy from being
adopted at the current time is important. For such policies, it may not be worthwhile to spend
much time analyzing other factors (e.g. fiscal and economic impact). However, by identifying
these critical barriers, you can be more readily able

Economic and budgetary impacts: Comparison of the costs to enact,
implement, and enforce the policy with the value of benefits
Budget
What are the costs and benefits associated
with the policy, from a budgetary
perspective?
E.g. for public (federal, state, local) and
private entities to enact, implement, and
enforce the policy?
Economic
How do costs compare to benefits (e.g. costsavings costs averted, return on investments,
cost-effectiveness, cost-benefit analysis,
etc.)?
How are costs and benefits distributed (e.g.
for individuals, businesses, government)?
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What is the timeline for costs and benefits?
Where are the gaps in the data/evidencebase?
*** note where there are concerns about the quality or amount of data

After describing policy options, the next step is to assess policy options. Using the same
criteria, policy options are independently scored based on a rating system seen in Table 2.

Table 2: Policy Analysis Table
Public
Health
Criteria Impact
Scoring
Definitio
ns

Low: small
reach, effect
size and impact
on disparate
populations

Feasibility
Low: No/small
likelihood of
being enacted

Economic and Budgetary Impact

Less favorable: High
costs to implement
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Less Favorable:
costs are high to
benefits

Medium: small
reach with
large effect size
or large reach
with small
effect size
Large: large
reach, effect
size, and
impact on
disparate
populations

Medium:
Moderate
likelihood of
being enacted

High: High
likelihood of
being enacted

Policy 1
Low/Medium/
High
Concerns about
the amount or
quality of data?
Yes/No

Low/Medium/
High
Concerns about
the amount or
quality of data?
Yes/No

Low/Medium/
High
Concerns about
the amount or
quality of data?
Yes/No

Low/Medium/
High
Concerns about
the amount or
quality of data?
Yes/No

Policy 2

Policy 3

Favorable: Moderate
cost to implement

Favorable: costs are
moderate relative to
benefits

More Favorable:
Low costs to
implement
Budget
Less
Favorable/Favorable/
More Favorable

More Favorable:
costs are low relative
to benefits
Economic
Less
Favorable/Favorable/
More Favorable

Concerns about the
amount or quality of
data? Yes/No
Less
Favorable/Favorable/
More Favorable

Concerns about the
amount or quality of
data? Yes/No
Less
Favorable/Favorable/
More Favorable

Concerns about the
amount or quality of
data? Yes/No
Less Favorable
Favorable/More
Favorable

Concerns about the
amount or quality of
data? Yes/No
Less
Favorable/Favorable/
More Favorable

Low/Medium/
Low/Medium/
High
High
Concerns about Concerns about
the amount or
the amount or
Concerns about the
Concerns about the
quality of data? quality of data? amount or quality of
amount or quality of
Yes/No
Yes/No
data? Yes/No
data? Yes/No
After policy options are assessed, policy options are evaluated against each other and
policy options are prioritized based on the overall analysis.
Domain 3 is Strategy and Policy Development. This step is to “develop a strategy for

furthering adoption of the policy solution” (Centers for Disease Control and Prevention, 2013).
After a policy option is prioritized, a strategy is defined to get the policy enacted. To accomplish
this, operational issues are clarified, information is shared, and, if needed, additional background
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work is conducted. To clarify operational issues, “identify how the policy will operate and what
steps are needed for policy implementation” (Centers for Disease Control and Prevention, 2013).
To share information, share the results to stakeholders; to disseminate the information, develop
products that “keep in mind the stakeholders’ information needs and preferred ways of receiving
information” (Centers for Disease Control and Prevention, 2013). This can be done via a
summarization sheet, presentation, meetings, or other methods. Lastly, additional background
work is conducted if needed. If the policy scored low in specific areas or there are concerns with
the data, the policy can be reworked to more effectively address the problem or issue.
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Chapter 5: Results
Using the CDC’s Policy Analytical Framework, first, data was synthesized to identify the
overarching problem that § 97-27-14 is not scientifically accurate and negatively impacts the
HIV crisis in Mississippi (Table 3).

Domain 1: Problem Identification
Step 1: Identify the Problem or Issue

Severity

Approximately 9,236
Mississippians living with HIV
As of 2017, rate of 14.3 per
100,000 population.
Ranked 9 in the nation for
diagnoses of HIV

Scope

Significantly impacts African
American men who have sex with
men, high rates of AIDS, current
law scientifically incorrect and
stigmatizing

Identified
Problem:

§ 97-27-14 is not scientifically
accurate and negatively impacts
the HIV crisis in Mississippi

Burden
Frequency

Table 3
Next, possible policy options were identified. Based on the National HIV/AIDS Strategy
for the United States: Updated to 2020, U.S. Department of Justice Civil Rights’ Best Practices
Guide to reform HIV-Specific Criminal Laws to Align with Scientifically-Supported Factors,
Georgia Code ANN. § 16-5-60, and the 2016 act proposed by Representative Hines to amend the
crime of endangerment for bodily substances, three possible policies were identified.
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Based off the 2016 amendment proposed by Representative Hines, the first policy option
amends Mississippi Code § 97-27-14 to include only blood and seminal fluid. The Policy 1
option states:
“It shall be unlawful for any person to knowingly expose another person to human
immunodeficiency virus (HIV). Prior knowledge and willing consent to the exposure is
a defense to a charge brought under this paragraph. A violation of this subsection shall
be a felony.
(2)(a) A person commits the crime of endangerment by bodily substance if the person
attempts to cause or knowingly causes a corrections employee, a visitor to a correctional
facility or another prisoner or offender to come into contact with blood or seminal fluid.
(b) As used in this subsection, the following definitions shall apply unless the context
clearly requires otherwise:
(i) “Corrections employee” means a person who is an employee or contracted employee
of a subcontractor of a department or agency responsible for operating a jail, prison,
correctional facility or a person who is assigned to work in a jail, prison or correctional
facility.
(ii) “Offender” means a person who is in the custody of the Department of Corrections.
(iii) “Prisoner” means a person confined in a county or city jail.
(c) A violation of this subsection is a misdemeanor unless the person violating this
section knows that he is infected with human immunodeficiency virus (HIV, in which
case it is a felony.
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(3) Any person convicted of a felony violation of this section shall be imprisoned for not
less than three (3) years nor more than ten (10) years and a fine of not more than Ten
Thousand Dollars ($10,000.00), or both.
(4) Any person guilty of a misdemeanor violation of this section shall be punished by
imprisonment in the county jail for up to one (1) year and may be fined One Thousand
Dollars ($1,000.00), or both.”
(5) The provisions of this section shall be in addition to any other provisions of law for
which the actions described in this section may be prosecuted.
The second policy option includes the clause “with the intent to transmit HIV” and also
only includes blood and seminal fluids in the list of bodily substances. This policy is based off
Georgia Code ANN. § 16-5-60, the National HIV/AIDS Strategy for the United States: Updated
to 2020, and the U.S. Department of Justice Civil Rights’ Best Practices Guide to reform HIVSpecific Criminal Laws to Align with Scientifically-Supported Factors. The Policy 2 Option
states:
It shall be unlawful for any person to knowingly expose another person to human
immunodeficiency virus (HIV) with the intent to transmit HIV. Prior knowledge and
willing consent to the exposure is a defense to a charge brought under this paragraph. A
violation of this subsection shall be a felony.
(2)(a) A person commits the crime of endangerment by bodily substance if the person
attempts to cause or knowingly causes a corrections employee, a visitor to a correctional
facility or another prisoner or offender to come into contact with blood or seminal fluid.
(b) As used in this subsection, the following definitions shall apply unless the context
clearly requires otherwise:
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(i) “Corrections employee” means a person who is an employee or contracted employee
of a subcontractor of a department or agency responsible for operating a jail, prison,
correctional facility or a person who is assigned to work in a jail, prison or correctional
facility.
(ii) “Offender” means a person who is in the custody of the Department of Corrections.
(iii) “Prisoner” means a person confined in a county or city jail.
(c) A violation of this subsection is a misdemeanor unless the person violating this
section intends to transmit HIV.
(3) Any person convicted of a felony violation of this section shall be imprisoned
for not less than three (3) years nor more than ten (10) years and a fine of not more than
Ten Thousand Dollars ($10,000.00), or both.
(4) Any person guilty of a misdemeanor violation of this section shall be punished by
imprisonment in the county jail for up to one (1) year and may be fined One Thousand
Dollars ($1,000.00), or both.
(5) The provisions of this section shall be in addition to any other provisions of law for
which the actions described in this section may be prosecuted.
The third policy option is to repeal Mississippi Code § 97-27-14. This option is based off
of recommendations by the National HIV/AIDS Strategy for the United States: Updated to 2020
and the general best practice suggested by the U.S. Department of Justice Civil Rights’ Best
Practices Guide to reform HIV-Specific Criminal Laws to Align with Scientifically-Supported
Factors. The Policy 3 option states:
Repeal Mississippi Code § 97-27-14.
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Next the policies were described and analyzed based on Public Health Impact,
Feasibility, and Economic and Budgetary Impacts using Table 1: Policy Analysis: Key
Questions. Tables 4-6 showcase the results.

Table 4: Policy Analysis: Key Questions
Policy 1 Option
Framing Questions
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What is the policy lever – is it legislative,
administrative, regulatory, other?
Legislative
What level of government institution will
implement?
How does the policy work/operate? (e.g. is it
mandatory? Will enforcement be necessary?
How is it funded? Who is responsible for
administering the policy?)
What are the objectives of the policy?
What is the legal landscape surrounding the
policy (e.g. court rulings, constitutionality)?
What is the historical context (e.g. has the
policy been debated previously)?
What are the experiences of other jurisdictions?
What is the value-added of the policy?
What are the expected short, intermediate, and
long-term outcomes?

What might be the unintended positive and
negative consequences of the policy?

State
This is related to criminal justice, so this will be
administered by the court system. Enforcement is
necessary because it is a criminal law.
The objectives of this policy are to amend the
existing law to be scientifically accurate and
reduce stigma.
Nationally: United States V. Moore, State: 2008
Shala Singleton Howell
The law has been debated previously. A similar
amendment was proposed in 2016 and failed.
33 states, 67 HIV-Specific criminal laws, Center
for Disease Control and Prevention and the
Department of Justice encourage laws to be
reassessed
Adds scientific accuracy to existing policy
Adds scientific accuracy when law is utilized; is
only a temporary solution and will need to be
amended again because the amendment still
furthers stigma and is not the ideal public health
solution
Does not include clause for criminal intent, could
further stigma with disparity in sentencing for
misdemeanor versus felony

Public Health Impact: Potential for the policy to impact risk factors, quality of
life, disparities, morbidity and mortality
How does the policy address the problem or
issue (e.g., increase access, protect from
exposure)?
What are the magnitude, reach, and distribution
of benefit and burden (including impact on risk
factor, quality of life, morbidity and mortality?
What population(s) will benefit? How much?
When?

Makes the law scientifically accurate by including
only bodily substances that can transmit HIV
Impact HIV/AIDS Mississippians: approximately
200 prisoners, over 400 diagnoses yearly in
Mississippi, over 9,000 living with HIV in
Mississippi
HIV/AIDS populations as the law is scientifically
correct. This has immediate impact as the
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amendment reduces misinformation thereby
reducing some stigma.
What population(s) will be negatively
impacted? How much? When?
Will the policy impact health disparities/health
equity? How?
Are there gaps in the data/evidence-base?

HIV/AIDS populations as the law is still HIVspecific and is thereby still stigmatizing.
The policy impacts health disparities in that
HIV/AIDS disproportionately impacts Black men
who have sex with men. The policy promotes
health equity by including scientifically correct
information.
No.

Feasibility*: Likelihood that the policy can be successfully adopted and
implemented
Political
International/national agencies encouraging reassessment of HIV criminalization laws. Similar
What are the current political forces including
amendment introduced in 2016 and failed. Original
political history, environment, and debate?
law used only once in 2008, but there may be other
instances where the law has been used that are not
as widely noted.
Mississippi Legislators (protecting Mississippians,
Who are the stakeholders, including supporters
getting re-elected, etc.), Mississippians living with
and opponents? What are their interests and
HIV/AIDS, HIV/AIDS advocacy organizations
values?
(equitable laws, decreasing stigma)
What are the potential social, educational, and
cultural perspectives associated with the policy
option (e.g. lack of knowledge, fear of change,
Lack of knowledge, stigma, fear, heteronormality,
force of habit)?
abstinence-plus education
What are the potential impacts of the policy on
other sectors and high priority issues (e.g.
sustainability, economic impact)?
Limited impact
Operational
What are the resource, capacity, and technical
needs developing, enacting, and implementing
the policy?
How much time is needed for the policy to be
enacted, implemented, and enforced?
How scalable, flexible, and transferable is the
policy?

Advocacy to lawmakers, mobilization of
HIV/AIDS advocates/community to educate
lawmakers, education, education about law to
prison systems
Minimum 6 months
The policy has the potential to be scalable, flexible,
and transferable in relation to Hepatitis B and
Hepatitis C-specific criminalization policies.
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*In assessing feasibility, identifying critical barriers that will prevent the policy from being adopted at
the current time is important. For such policies, it may not be worthwhile to spend much time
analyzing other factors (e.g. fiscal and economic impact). However, by identifying these critical
barriers, you can be more readily able

Economic and budgetary impacts: Comparison of the costs to enact, implement,
and enforce the policy with the value of benefits
Budget
What are the costs and benefits associated with
the policy, from a budgetary perspective?
Low costs
E.g. for public (federal, state, local) and private
entities to enact, implement, and enforce the
policy?
No cost change from previous policy
Economic
There is limited cost change from the previous
policy, yet in amending the law to be scientifically
accurate, the policy reduces stigma. Stigma is often
How do costs compare to benefits (e.g. costa reason people do not get tested for HIV or do not
savings costs averted, return on investments,
access needed resources, and so, by alleviating
cost-effectiveness, cost-benefit analysis, etc.)?
stigma, persons living with HIV will access needed
resources sooner preventing the spread of the virus
and more costly health problems.
Healthcare industry as less costly health services,
those living with HIV/AIDS by accessing needed
How are costs and benefits distributed (e.g. for
health resources sooner and with less stigma,
individuals, businesses, government)?
prison system having less prisoners based on more
correct laws
What is the timeline for costs and benefits?
6 months in relation with enactment
Where are the gaps in the data/evidence-base?
No
Table 4 entailing the Policy 1 Option

Table 5: Policy Analysis: Key Questions
Policy 2 Option
Framing Questions
What is the policy lever – is it legislative,
administrative, regulatory, other?
What level of government institution will
implement?

Legislative
State
This is related to criminal justice, so this will be
administered by the court system. Enforcement is
necessary because it is a criminal law.

How does the policy work/operate? (e.g. is it
mandatory? Will enforcement be necessary?
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How is it funded? Who is responsible for
administering the policy?)
The objectives of this policy are to amend the
existing law to be scientifically accurate, to
decrease stigma, and include a cause for criminal
intent.
Nationally: United States V. Moore, State: 2008
Shala Singleton Howell

What are the objectives of the policy?
What is the legal landscape surrounding the
policy (e.g. court rulings, constitutionality)?
What is the historical context (e.g. has the
policy been debated previously)?

What are the experiences of other jurisdictions?

What is the value-added of the policy?
What are the expected short, intermediate, and
long-term outcomes?

What might be the unintended positive and
negative consequences of the policy?

The law has been debated previously. A much
more simplified amendment was proposed in 2016
and failed.
33 states, 67 HIV-Specific criminal laws, Center
for Disease Control and Prevention and the
Department of Justice encourage laws to be
reassessed encouraging clauses for intent if not
repeal. There are several laws similar to this in
states such as Georgia.
Adds scientific accuracy to existing policy, adds
criminal intent to a criminal law
Adds scientific accuracy when law is utilized;
includes clause relating to criminal intent.
Potentially further stigma because of the difference
between felony and misdemeanor, possibly
stigmatize HIV as a possible weapon. Potentially
makes the law more feasible in appeal to
lawmakers and adds protection to those living with
HIV who do not have criminal intent and those
who could be victim to criminal intent as
exemplified in domestic violence.

Public Health Impact: Potential for the policy to impact risk factors, quality of
life, disparities, morbidity and mortality
How does the policy address the problem or
issue (e.g., increase access, protect from
exposure)?
What are the magnitude, reach, and distribution
of benefit and burden (including impact on risk
factor, quality of life, morbidity and mortality?
What population(s) will benefit? How much?
When?
What population(s) will be negatively
impacted? How much? When?
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Makes the law scientifically accurate, adds
criminal intent to decrease stigma
Impact HIV/AIDS Mississippians: approximately
200 prisoners, over 400 diagnoses yearly in
Mississippi, over 9,000 living with HIV in
Mississippi
HIV/AIDS populations as the law is scientifically
correct/includes criminal clause to decriminalize
HIV/AIDS populations as the law is still HIVspecific and thereby still stigmatizing

Will the policy impact health disparities/health
equity? How?

Are there gaps in the data/evidence-base?

The policy impacts health disparities in that
HIV/AIDS disproportionately impacts Black men
who have sex with men. The policy promotes
health equity by including scientifically correct
information and accounts for criminal intent,
decriminalizing certain behaviors.
No

Feasibility*: Likelihood that the policy can be successfully adopted and
implemented
Political
International/national agencies encouraging reassessment of laws. Similar amendment failed in
2016. Original law used only once in 2008, but
What are the current political forces including
there may be other instances where the law has
political history, environment, and debate?
been used that are not as widely noted. Amending
HIV-specific criminalization laws to include
criminal intent is suggested by the Department of
Justice, and these policies are seen in other states.
Mississippi Legislators (protecting Mississippians,
Who are the stakeholders, including supporters
getting re-elected, etc.), Mississippians living with
and opponents? What are their interests and
HIV/AIDS, HIV/AIDS advocacy organizations
values?
(equitable laws, decreasing stigma)
What are the potential social, educational, and
cultural perspectives associated with the policy
option (e.g. lack of knowledge, fear of change,
Lack of knowledge, stigma, fear, heteronormality,
force of habit)?
abstinence-plus education,
What are the potential impacts of the policy on
other sectors and high priority issues (e.g.
sustainability, economic impact)?
Limited impact
Operational
Advocacy to lawmakers, mobilization of
What are the resource, capacity, and technical
HIV/AIDS advocates/community to educate
needs developing, enacting, and implementing
lawmakers, education, education about law to
the policy?
prison systems
How much time is needed for the policy to be
enacted, implemented, and enforced?
Minimum 6 months
The policy has the potential to be scalable, flexible,
How scalable, flexible, and transferable is the
and transferable in relation to Hepatitis B and
policy?
Hepatitis C-specific criminalization policies.
*In assessing feasibility, identifying critical barriers that will prevent the policy from being adopted at
the current time is important. For such policies, it may not be worthwhile to spend much time
analyzing other factors (e.g. fiscal and economic impact). However, by identifying these critical
barriers, you can be more readily able

Economic and budgetary impacts: Comparison of the costs to enact, implement,
and enforce the policy with the value of benefits
33

Budget
What are the costs and benefits associated with
the policy, from a budgetary perspective?
Low costs
E.g. for public (federal, state, local) and private
entities to enact, implement, and enforce the
policy?
No cost change from previous policy
Economic
There is limited cost change from the previous
policy, yet in amending the law to be scientifically
accurate and including a clause for criminal intent,
How do costs compare to benefits (e.g. costthe policy reduces stigma. Stigma is often a reason
savings costs averted, return on investments,
people do not get tested for HIV or do not access
cost-effectiveness, cost-benefit analysis, etc.)?
needed resources, and so, by alleviating stigma,
persons living with HIV will access needed
resources sooner preventing the spread of the virus
and more costly health problems.
Healthcare industry as less costly health services,
those living with HIV/AIDS by accessing needed
How are costs and benefits distributed (e.g. for
health resources sooner and with less stigma,
individuals, businesses, government)?
prison system having less prisoners based on more
correct laws
What is the timeline for costs and benefits?
6 months in relation with enactment
Where are the gaps in the data/evidence-base?
No
Table 5 entailing Policy 2 option.

Table 6: Policy Analysis: Key Questions
Policy 3 Option
Framing Questions
What is the policy lever – is it legislative,
administrative, regulatory, other?
Legislative
What level of government institution will
implement?

State

How does the policy work/operate? (e.g. is it
mandatory? Will enforcement be necessary?
How is it funded? Who is responsible for
administering the policy?)

This is related to criminal justice, so this will be
administered by the court system. Because this is a
repeal of a criminal law, enforcement is no longer
necessary.
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The objectives of this policy are to decrease stigma
for HIV/AIDS populations as based on the Center
for Disease Control and Prevention and the
Department of Justice suggestions and best
practices.

What are the objectives of the policy?

What is the legal landscape surrounding the
policy (e.g. court rulings, constitutionality)?

Nationally: United States V. Moore, State: 2008
Shala Singleton Howell

What is the historical context (e.g. has the
policy been debated previously)?

The law has been debated previously. A less
extreme was proposed in 2016 and failed.
33 states, 67 HIV-Specific criminal laws, Center
for Disease Control and Prevention and the
Department of Justice encourage laws to be
reassessed

What are the experiences of other jurisdictions?

Decreases stigma associated with criminalizing
HIV

What is the value-added of the policy?
What are the expected short, intermediate, and
long-term outcomes?
What might be the unintended positive and
negative consequences of the policy?

Ultimately decrease stigma for those living with
HIV
Fear related to HIV, increased education of
lawmakers an and other communities

Public Health Impact: Potential for the policy to impact risk factors, quality of
life, disparities, morbidity and mortality
How does the policy address the problem or
issue (e.g., increase access, protect from
exposure)?

Decriminalizes HIV thereby decreasing stigma
related to HIB

What are the magnitude, reach, and distribution
of benefit and burden (including impact on risk
factor, quality of life, morbidity and mortality?
What population(s) will benefit? How much?
When?

Impact HIV/AIDS Mississippians: approximately
200 prisoners, over 400 diagnoses yearly in
Mississippi, over 9,000 living with HIV in
Mississippi
HIV/AIDS populations
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Conversation surrounding the policy could
negatively impact HIV/AIDS populations initially.
General population could be negatively impacted
regarding potential for domestic violence and
criminal intent, yet these are mild concerns that
have the potential to be addressed in other laws.

What population(s) will be negatively
impacted? How much? When?

Will the policy impact health disparities/health
equity? How?

The policy impacts health disparities in that
HIV/AIDS disproportionately impacts Black
MSM. The policy promotes health equity by
decriminalizing HIV.

Are there gaps in the data/evidence-base?

No

Feasibility*: Likelihood that the policy can be successfully adopted and
implemented
Political
International/national agencies encouraging reassessment of HIV criminalization laws. Similar
amendment introduced in 2016 and failed. Original
What are the current political forces including
law used only once in 2008, but there may be other
political history, environment, and debate?
instances where the law has been used that are not
as widely noted. Repealing HIV-specific criminal
laws is the best practice as suggested by the
Department of Justice.
Mississippi Legislators (protecting Mississippians,
Who are the stakeholders, including supporters
getting re-elected, etc.), Mississippians living with
and opponents? What are their interests and
HIV/AIDS, HIV/AIDS advocacy organizations
values?
(equitable laws, decreasing stigma)
What are the potential social, educational, and
cultural perspectives associated with the policy
Lack of knowledge, stigma, fear, heteronormality,
option (e.g. lack of knowledge, fear of change,
abstinence-plus education, want to protect
force of habit)?
Mississippi citizens
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What are the potential impacts of the policy on
other sectors and high priority issues (e.g.
sustainability, economic impact)?

Limited impact
Operational
Advocacy to lawmakers, mobilization of
What are the resource, capacity, and technical
HIV/AIDS advocates/community to educate
needs developing, enacting, and implementing
lawmakers, education, education about law to
the policy?
prison systems
How much time is needed for the policy to be
enacted, implemented, and enforced?
Minimum 6 months
The policy has the potential to be scalable, flexible,
and transferable in relation to Hepatitis B and
Hepatitis C-specific criminalization policies.

How scalable, flexible, and transferable is the
policy?

*In assessing feasibility, identifying critical barriers that will prevent the policy from being adopted at
the current time is important. For such policies, it may not be worthwhile to spend much time
analyzing other factors (e.g. fiscal and economic impact). However, by identifying these critical
barriers, you can be more readily able

Economic and budgetary impacts: Comparison of the costs to enact, implement,
and enforce the policy with the value of benefits
Budget
What are the costs and benefits associated with
the policy, from a budgetary perspective?

Low costs

E.g. for public (federal, state, local) and private
entities to enact, implement, and enforce the
policy?

No cost change from previous policy
Economic

How do costs compare to benefits (e.g. costsavings costs averted, return on investments,
cost-effectiveness, cost-benefit analysis, etc.)?
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There is limited cost change from the previous
policy, yet in decriminalizing HIV, the policy
greatly reduces stigma. Stigma is often a reason
people do not get tested for HIV or do not access
needed resources, and so, by alleviating stigma,
persons living with HIV will access needed
resources sooner preventing the spread of the virus
and more costly health problems.

How are costs and benefits distributed (e.g. for
individuals, businesses, government)?

What is the timeline for costs and benefits?
Where are the gaps in the data/evidence-base?
Table 6 entailing Policy 3 option.

Healthcare industry as less costly health services,
those living with HIV/AIDS by accessing needed
health resources sooner and with less stigma,
prison system having less prisoners based on more
correct laws
6 months in relation with enactment
No

After describing policy options, the policy options were scored independently based on
Public Health Impact, Feasibility and Economic and Budgetary Impact. Table 6 shows the
scoring results.

Table 7: Policy Analysis Table
Criteria

Public Health Impact Feasibility

Scoring
Definitions Low: small reach, effect
size and impact on
disparate populations
Medium: small reach
with large effect size or
large reach with small
effect size
Large: large reach,
effect size, and impact
on disparate populations
Policy 1

Low

Policy 2

Concerns about the
amount or quality of
data? No
Medium

Low: No/small
likelihood of being
enacted
Medium:
Moderate
likelihood of being
enacted

Economic and Budgetary
Impact
Less favorable:
High costs to
implement

Favorable:
Moderate cost to
implement
More
High: High
Favorable: Low
likelihood of being costs to
enacted
implement
Budget
Medium
More Favorable
Concerns about
Concerns about the the amount or
amount or quality
quality of data?
of data? No
No
Medium
More Favorable
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Less Favorable:
costs are high to
benefits
Favorable: costs
are moderate
relative to
benefits
More Favorable:
costs are low
relative to
benefits
Economic
More Favorable
Concerns about
the amount or
quality of data?
No
More Favorable

Policy 3

Concerns about the
amount or quality of
data? No
High
Concerns about the
amount or quality of
data? No

Concerns about
Concerns about the the amount or
amount or quality
quality of data?
of data? No
No
Low
More Favorable
Concerns about
Concerns about the the amount or
amount or quality
quality of data?
of data? No
No

Concerns about
the amount or
quality of data?
No
More Favorable
Concerns about
the amount or
quality of data?
No

Table 7
Based on the policy analysis, Policy 2 is prioritized, but concerns are noted for the overall
public health impact.
Finally, during Strategy and Policy Development, a strategy is created to account for the
public health impact.
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Domain 3: Strategy and Policy Development
Discuss Policy 2 with relevant
stakeholders, educate Mississippi
Clarifying Operational state legislators about implications of
Issues
current policy, get a Mississippi state
legislator to sponsor the bill,
continue to advocate for bill

Sharing Information

Share with relevant stakeholders
including AIDS Services Coalition,
My Brother's Keeper, Inc, Center for
Mississippi Health Policy,
Mississippi legislature public health
committees, Mississippians living
with HIV

Based on concerns with Policy 2's
public health impact, modify the
Conducting Additional policy strategy to be more
Background Work
incremental in advocating for Policy
2 while continuing to work for
Policy 3
Table 8
As the strategy and policy development in Table 7 show, the prioritized policy is Policy
option 2 to amend Mississippi’s HIV-specific criminalization law to be scientifically correct and
include a criminalization clause. Because this is not the ideal public health solution, the strategy
is modified to be more incremental in building the foundation for Mississippi’s HIV-specific
criminalization law to be repealed while advocating for the current best policy option, Policy
Option 2.
Enactment of Policy 2 while building the foundation to decriminalize HIV is done by first
discussing the current policy option and strategy with stakeholders including AIDS Services
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Coalition, My Brother’s Keeper, Inc, Center for Mississippi Health Policy, Public Health
Committees in the Mississippi Legislature, Mississippians living with HIV, and other relevant
stakeholders. Once the policy option and strategy are discussed, see if changes should be made to
the policy option and/or strategy. After discussing the policy and strategy with stakeholders,
begin educating Mississippi state legislators about the implications of the current policy while
also addressing the HIV/AIDS crisis in Mississippi and implications of HIV-criminalization as a
whole. After educating legislators, get a Mississippi state legislator to sponsor the bill. Finally,
mobilize stakeholders to continue to advocate for the bill throughout the Mississippi House of
Representatives and Senate.
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Chapter 6: Findings and Discussion
After identifying the overarching problem being that Mississippi Code § 97-27-14 is not
scientifically accurate and negatively impacts the HIV crisis in Mississippi, three policy options
were identified. Policy 1 amends the original policy to only blood and seminal fluid, Policy 2
amends the original policy to only include blood and seminal fluid and includes criminal intent,
and Policy 3 is to repeal Mississippi Code § 97-27-14.
When describing the policy options, there were varied concerns with each policy. Policy
1 amends the original law to be scientifically correct, yet the law is still stigmatizing as it does
not include a clause for criminal intent, includes the disparity in sentencing for a misdemeanor
versus felony, singles out persons living with HIIV, and further stigmatizes those living with
HIV. Policy 2 amends the original law by including criminal intent and scientifically correct
information, yet this policy option still stigmatizes as the policy singles out persons living with
HIV, includes the disparity in sentencing for a misdemeanor versus felony, and still further
stigmatizes person living with HIV in the idea of HIV as a weapon. Policy 3 is the repeal of
Mississippi Code § 97-27-14; while this policy option is the least stigmatizing option for persons
living with HIV, the major concern is regarding feasibility. While all of the policy options regard
extensive education for policy makers, repealing Mississippi Code § 97-27-14 requires the most
extensive educational measures and raises concerns with the concept of protecting
Mississippians.
After describing policy options, Policy 1, 2, and 3 were assessed. Policy 1 scored low for
Public Health Impact, medium for Feasibility, and more favorable for both Economic and
Budgetary Impact. While Policy 1 amends the law to be scientifically accurate, the law does not
account for criminal intent, which makes it have a limited public health impact. Also, this law is
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still stigmatizing because this is still a HIV-specific criminal law and the discrepancy still exists
between misdemeanor and felony. Despite the very similar amendment to the 2016 Mississippi
Legislature failing, this policy has a moderate likelihood of being enacted if proper advocacy
measures are put in place including stakeholder mobilization and education of lawmakers. This
policy change would ultimately cost the same as Mississippi Code § 97-27-14 while possibly
reducing healthcare costs through the alleviation of stigma ultimately making this policy more
favorable for Economic and Budgetary Impact.
Policy 2 scored medium for Public Health Impact, medium for Feasibility, and more
favorable for both Economic and Budgetary Impact. Policy 2 amends the law to be scientifically
accurate and includes the clause of criminal intent to be a felony. Yet, this policy is still
classified as a HIV-specific law furthering stigma, and there is still the clause for a misdemeanor,
which does not account for criminal intent. Yet, HIV-specific policies are created with the
intention of protecting citizens, despite limited evidence that it works, and so, this policy’s
criminal intent clause benefits both parties as it accounts for those affected by criminal intent and
persons living with HIV who did not have criminal intent. Overall, this policy has a medium
public health impact because of its large reach and small effect size. Because this policy appeals
to various stakeholders in accounting for criminal intent, this policy has a moderate likelihood of
being enacted if proper advocacy measures are put in place including the mobilization of
stakeholders and continued educational efforts of lawmakers. Policy 2 would ultimately cost the
same as Mississippi Code § 97-27-14 while possibly reducing healthcare costs through the
alleviation of stigma and possibly reduce criminalization rates ultimately making this policy
more favorable for Economic and Budgetary Impact.
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Policy 3 scored large for Public Health Impact, low for Feasibility, and more favorable
for both Economic and Budgetary Impact. Policy 3 is the repeal of Mississippi Code § 97-27-14.
This policy has the greatest public health impact in that this repeal decriminalizes HIV greatly
reducing stigma for people living with HIV. While this policy has the most significant public
health impact, based on current attitudes, understanding, and pre-existing stigma of HIV by
Mississippi legislators and other Mississippians, this policy has a significantly lower chance of
being implemented. Policy 3 would ultimately cost the same as Mississippi Code § 97-27-14
while possibly reducing healthcare costs through the alleviation of stigma and ultimately
reducing criminalization rates making this policy more favorable for Economic and Budgetary
Impact.
Once policy options were assessed and scored, Policy 2 was prioritized based on the
moderate Public Health Impact and Feasibility, yet concerns were noted that Policy 2 is not the
ideal public health solution. To account for the fact that the ideal public health solution is to
repeal the HIV-specific criminal law, the strategy was modified to be more incremental in
advocating for the immediate policy solution to be Policy 2 while building the foundation and
continuing to work for Policy 3. This is done by first discussing Policy 2 and the strategy with
relevant stakeholders to possibly modify the policy and strategy and mobilize stakeholders. After
discussing Policy 2 with stakeholders, educate Mississippi legislators about the Mississippi
HIV/AIDS crisis, implications of Mississippi Code § 97-27-14, and overall stigmatizing effects
of HIV-specific criminalization while advocating for Policy 2. In this education and advocacy
phase, the immediate policy solution is advocated for while the educational foundations and
decrease of stigma are beginning for the foundation for the repeal of Mississippi Code § 97-27-
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14. After this step, get a Mississippi legislator to sponsor the bill and continue to advocate for the
bill as it goes through Mississippi State House of Representatives and Senate.
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Chapter 7: Conclusion and Directions for Future Research
Ultimately, Mississippi § 97-27-14 must be reformed to reflect national standards and to
decrease misinformation and stigma for those living with HIV in Mississippi. The current best
policy option based on Public Health Impact and Feasibility is to amend the code to be
scientifically accurate and include a clause for criminal intent. Because this is not the ideal public
health solution, the strategy must include building the foundation to continually work for
ultimately repealing Mississippi’s HIV-specific criminalization law while advocating for the
current best policy solution. Amidst the HIV/AIDS crisis in Mississippi, it is critical that
Mississippi Code § 97-27-14 is reformed to decrease stigma that continues to hurt Mississippians
living with HIV.
The findings of this policy analysis suggest directions for future research. Mississippi is
currently ranked second in the nation for percentages of prisoners living with HIV. This is an
alarming number, and yet, no literature exists about the high percentage, and it is not mentioned
in the Mississippi State Department of Health 2017-2021 Integrated HIV Prevention and Care
Plan. It is critical that the high percentage is further researched, so that the health needs of this
population are met. Secondly, Hepatitis B and Hepatitis C are included in Mississippi Code § 9727-14, yet for the purpose of this study, Hepatitis B and C were not included. Further research
and analysis should be done for Hepatitis B and C-specific criminalization laws to determine if
the suggested policy option determined for Mississippi’s HIV-criminalization laws would be
applicable. Lastly, there are numerous policies by the Mississippi Department of Health
regarding HIV treatment and prevention efforts. It is important for these laws to be re-examined
and reformed to meet national standards, improve access for those living with HIV, and ensure
these policies meet the health needs of vulnerable Mississippians.
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